NSP Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.00 0.00
Volume 100000 1 Year 0.00 0.00
52 Week High 0.01
52 Week Low 0.01
NSP Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.01
Support 1 0.01
Support 2 0.01
ASX Australia Most Active Stocks
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
FMG 5.31 1.92%
FMG 5.31 1.92%
TLS 4.22 0.00%
TLS 4.22 0.00%
TLS 4.22 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
PGS 0.02 100.00%
PGS 0.02 100.00%
PGS 0.02 100.00%
PGS 0.02 100.00%
LML 0.05 66.67%
LML 0.05 66.67%
ETE 0.03 50.00%
ETE 0.03 50.00%
BNV 0.03 50.00%
More..
ASX Australia Top Losers Stocks
FUN 0.00 -100.00%
FUN 0.00 -100.00%
FUN 0.00 -100.00%
RBR 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
More..

NuSep Holdings Ltd (ASX: NSP)

NSP Technical Analysis 5
As on 4th Jul 2016 NSP Share Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
NSP Target for April
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
NSP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.nusep.com
NSP Address
NSP
30 Richmond Road
Homebush, NSW 2140
Australia
Phone: 61 2 8415 7300
Fax: 61 2 8415 7399
NSP Latest News
Needle Action Activity Spotted in Memphasys Ltd (MEM.AX)   TCT   - 28th Apr 17
Unusual Activity Spotted in China Jinmao Holdings Group Ltd (0817.HK)   Concord Register   - 27th Apr 17
BRIEF-Memphasys says co and Prime Biologics Pte agreed by mutual consent in ...   Reuters   - 17th Feb 17
Surefire Resources NL is Wednesday's ASX % Gainer in morning trade   Proactive Investors Australia   - 11th Jan 17
Lakes Oil tops ASX % Gainers intra-day   Proactive Investors Australia   - 22nd Dec 16
NuSep Holdings Ltd in ASX trading halt   Proactive Investors Australia   - 22nd Apr 16
NuSep Holdings Ltd poised to reveal outcome of negotiations   Proactive Investors Australia   - 21st Apr 16
Iclusig now available under Australian PBS for chronic myeloid leukemia   The Pharma Letter (registration)   - 02nd Nov 15
NuSep Holdings company PrIME Biologics banks SGD$6.55M   Proactive Investors Australia   - 19th Jun 14
NuSep Holdings snares Malaysian company Xeraya Capital Labuan as cornerstone ...   Proactive Investors Australia   - 24th Dec 13
Interactive Technical Analysis Chart NuSep Holdings Ltd ( NSP ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NuSep Holdings Ltd
NSP Business Profile
NuSep Holdings Limited develops, manufactures, and sells pre-cast electrophoresis gels, separations equipment and consumables, and other biological products for the life science market. The company offers nUView Tris-Glycine and Tris-HEPES precast gels, as well as buffers, protein molecular weight markers, and stains and accessories. It also provides ProteomeSep, a preparative electrophoresis instrument that allows charged molecules to migrate through hydrophilic membranes into various fractions when a voltage is applied; and SpermSep, a patented sperm separation system for the use in artificial reproductive technology applications. In addition, the company manufactures therapeutic human blood plasma products. Further, it provides diagnostic products that include general reagents comprising calcium chloride and heparin resistant calcium chloride; and LA reagents under the Kaogen brand name, as well as Von Willebrand factor reagents. Additionally, the company offers detergents for protein crystallization and FPLC/HPLC chromatography columns for a range of applications. NuSep Holdings Limited has operations in Australia, the United States, Singapore, Europe, and other countries. The company is headquartered in Homebush, Australia.